Jornay PM, an ADHD Med Dosed in the Evening, Now Available
The attention deficit hyperactivity disorder (ADHD) treatment Jornay PM (methylphenidate HCI; Ironshore) is now available in the US. Jornay PM is indicated for patients 6 years of age and older and is intended for dosing in the evening.
https://www.empr.com/home/news/jornay-pm-an-adhd-med-dosed-in-the-evening-now-available/
Other Articles in this Edition
Jornay PM, an ADHD Med Dosed in the Evening, Now Available
Are People with ADHD More Creative?
Bringing mental health care into pediatricians’ offices works, finds five-year study
What to know about executive function disorder
How Cooking Made Me See My ADHD as a Talent Instead of a Shame